Lucosky Brookman Client Lucy Scientific Discovery, Inc. Acquires High Times Intellectual Property
Congratulations to Lucosky Brookman’s client Lucy Scientific Discovery, Inc. (NASDAQ: LSDI) on announcing a significant milestone in its…
Read MoreThe Latest News from Lucosky Brookman
Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions. Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here.
Recruiter.com Closes $1 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
Congratulations to our client Recruiter.com Group, Inc. (NASDAQ: RCRT) (NASDAQ: RCRTW) ("Recruiter.com"), a prominent on-demand recruiting…
Read More
Lucosky Brookman Congratulates its client Tevva on Proposed Merger Agreement with ElectraMeccanica
Lucosky Brookman LLP is pleased to extend its congratulations to its client, Tevva, on the recently announced proposed merger agreement…
Read More
Lucosky Brookman Serves as Special Nasdaq Counsel for Sacks Parente Golf's IPO and Nasdaq Listing
Lucosky Brookman is thrilled to announce its successful role as Special Nasdaq Counsel for Sacks Parente Golf, Inc. (NASDAQ:SPGC) in its…
Read More
Lucosky Brookman Congratulates SRM Entertainment, Inc. on Successful IPO and Spinoff
Lucosky Brookman LLP, is delighted to extend its heartfelt congratulations to SRM Entertainment, Inc. on the successful pricing of its initial…
Read More
Lucosky Brookman Congratulates its client Chardan Capital Market and VinFast Auto Ltd.’s on Nasdaq Listing and Successful Business Combination
Lucosky Brookman is thrilled to extend its warmest congratulations to the VinFast Auto Ltd. management team and its client, Chardan Capital…
Read More
NeurAxis, Inc. Announces Successful Pricing of its $6.5 Million Initial Public Offering
Lucosky Brookman’s client NeurAxis, Inc. (AMEX: NRXS), a pioneering medical technology company specializing in the development of…
Read More
Lucosky Brookman Represents Kingswood Investments in MIRA Pharmaceuticals, Inc.'s pricing of $8.9 Million Initial Public Offering and Nasdaq Listing
Lucosky Brookman congratulates its client Kingswood Investments, a division of Kingswood Capital Partners, LLC, in its role as the sole bookrunner…
Read More
Lucosky Brookman Represents Spartan Capital Securities, LLC in Janover Inc.'s $5.65 Million Initial Public Offering
Lucosky Brookman is proud to announce its representation of Spartan Capital Securities, LLC in Janover Inc.'s initial public offering (IPO).…
Read More
Anchor Investors Fall Out Of Favor As Micro-Cap IPO Landscape Evolves
Joseph Lucosky’s article featured on Forbes Business Council: The winds of change are blowing in the IPO market.
Read More